- Cardiovascular Risk Factors and Morbidity in Long-Term Survivors of Testicular Cancer: A 20-Year Follow-Up Study
[作者:Haugnes, HS; Wethal, T; Aass, N; Dahl, O; Klepp, O; Langberg, CW; Wilsgaard, T; Bremnes, RM; Fossa, SD,期刊:Journal of clinical oncology, 页码:4649-4657 , 文章类型: Article,,卷期:2010年28-30]
- Purpose To evaluate the prevalence of cardiovascular risk factors and long-term incidence of cardiovascular disease (CVD) in survivors of testicular cancer (TC). Methods Overall, 990 men treated for unilateral TC (1980 t...
- Hematopoietic Neoplasm of the Stomach
[作者:Joseph, S; Thomas, P; Lalich, D; Mathur, SC; McGregor, DH; Reese, J,期刊:Journal of clinical oncology, 页码:E593-E595 , 文章类型: Article,,卷期:2010年28-30]
-
- Lung Adenocarcinoma From East Asian Never-Smokers Is a Disease Largely Defined by Targetable Oncogenic Mutant Kinases
[作者:Sun, YH; Ren, Y; Fang, ZY; Li, CG; Fang, R; Gao, B; Han, XK; Tian, WD; Pao, W; Chen, HQ; Ji, HB,期刊:Journal of clinical oncology, 页码:4616-4620 , 文章类型: Article,,卷期:2010年28-30]
- Purpose To determine the proportion of lung adenocarcinomas from East Asian never-smokers who harbor known oncogenic driver mutations. Patients and Methods In this surgical series, 52 resected lung adenocarcinomas from n...
- Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer: Final Results of the VICTOR Trial
[作者:Midgley, RS; McConkey, CC; Johnstone, EC; Dunn, JA; Smith, JL; Grumett, SA; Julier, P; Iveson, C; Yanagisawa, Y; Warren, B; Langman, MJ; Kerr, DJ,期刊:Journal of clinical oncology, 页码:4575-4580 , 文章类型: Article,,卷期:2010年28-30]
- Purpose Laboratory and case-control studies suggest a pivotal role for the cyclooxygenase-2 ( COX-2) pathway in colorectal carcinogenesis. The purpose of this study was to test whether the COX-2 inhibitor rofecoxib could...
- Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor-Positive Advanced Breast Cancer
[作者:Di Leo, A; Jerusalem, G; Petruzelka, L; Torres, R; Bondarenko, IN; Khasanov, R; Verhoeven, D; Pedrini, JL; Smirnova, I; Lichinitser, MR; Pendergrass, K; Garnett, S; Lindemann, JPO; Sapunar, F; Martin, M,期刊:Journal of clinical oncology, 页码:4594-4600 , 文章类型: Article,,卷期:2010年28-30]
- Purpose We compared fulvestrant 500 mg regimen with the approved dose of fulvestrant 250 mg per month for treatment of postmenopausal women with estrogen receptor-positive advanced breast cancer who experienced progressi...
- Hepatitis C Virus Seromarkers and Subsequent Risk of Hepatocellular Carcinoma: Long-Term Predictors From a Community-Based Cohort Study
[作者:Lee, MH; Yang, HI; Lu, SN; Jen, CL; Yeh, SH; Liu, CJ; Chen, PJ; You, SL; Wang, LY; Chen, WJ; Chen, CJ,期刊:Journal of clinical oncology, 页码:4587-4593 , 文章类型: Article,,卷期:2010年28-30]
- Purpose Hepatitis C virus (HCV) contributes to one third of hepatocellular carcinoma cases worldwide. Long-term predictors for HCV-related hepatocellular carcinoma are essential for early intervention. Serum HCV RNA and ...
|